Discover open access scientific publications

Search, annotate, share and cite publications

Publications by David Kallend

Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial

Internal Medicine

Specialized Nursing

English

Related publications

Effects of Currently Prescribed LDL-C-lowering Drugs on PCSK9 and Implications for the Next Generation of LDL-C-lowering Agents

Lipids in Health and Disease

Clinical Biochemistry

English

Incorporating and Interpreting Regulatory Guidance on Estimands in Diabetes Clinical Trials: The PIONEER 1 Randomized Clinical Trial as an Example

Diabetes, Obesity and Metabolism

Internal Medicine

English

A 3-Year Prospective Randomized Controlled Clinical Trial of Group Care in Type 1 Diabetes

Nutrition, Metabolism and Cardiovascular Diseases

Cardiovascular Medicine

English

Postprandial Metabolic Effects of Fructose and Glucose in Type 1 Diabetes Patients: A Pilot Randomized Crossover Clinical Trial

Archives of endocrinology and metabolism

English

Disadvantages of Current LDL-cholesterol Lowering and the Role of PCSK9 Inhibitors.

Cardiologia Croatica

Cardiovascular Medicine

English

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1

Internal Medicine

Specialized Nursing

English

The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes

Internal Medicine

English

PCSK9 Is Increased in Youth With Type 1 Diabetes

Internal Medicine

Specialized Nursing

English

A Randomized Clinical Trial Aimed at Preventing Poor Psychosocial and Glycemic Outcomes in Teens With Type 1 Diabetes (T1D)

Contemporary Clinical Trials

English